VISEN Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, VISEN Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $51.51. The average 1-year stock price forecast is 156.27% higher than the current stock price, while the lowest is $50.47 (+151.09%) and the highest is $52.56 (+161.49%).

Price Target: $51.51 (+156.27%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$50.47	$51.51	$51.51	$52.56
Change	+151.09%	+156.27%	+156.27%	+161.49%

Analyst Ratings

The average analyst rating for VISEN Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Dec '25	Jan '26	Feb '26	Mar '26	May '26
Strong Buy	2	2	2	1	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	2	2	2

Financial Forecast

Revenue This Year

67.73M

from 136.00K

49,704.88%

from 136.00K

Revenue Next Year

447.41M

from 67.73M

560.53%

from 67.73M

EPS This Year

-2.12

from -2.44

EPS Next Year

-2.30

from -2.12

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-2.30M	-1.67M	2.78M	136.00K	67.73M
Revenue Growth	-	-	-	-95.10%	49,704.88%
Gross Profit	-2.30M	-1.67M	2.78M	-10.00K	46.47M
Gross Margin	100.00%	100.00%	100.00%	-7.35%	68.60%
Operating Income	-359.29M	-139.30M	-174.18M	-239.82M	-245.67M
Net Income	-288.97M	-249.57M	-182.24M	-253.42M	-99.00M
EPS	-	-	-	-2.44	-2.12
Free Cash Flow	-	-67.66M	-63.57M	-366.73M	-138.56M
No. Analysts	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue	2026	2027	2028
High	67.7M
Avg	67.7M
Low	67.7M

Revenue Growth

Revenue Growth	2026	2027	2028
High	49,704.9%
Avg	49,704.9%
Low	49,704.9%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-2.12
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-